Brief: Aequus receives approval for short form base shelf prospectus to raise up to C$20 mln
Aug 16 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* Aequus receives approval for short form base shelf
prospectus to raise up to C$20,000,000
* Aequus Pharmaceuticals Inc - New filing replaces company's
existing base shelf prospectus, which expired on August 6, 2017
Source text for Eikon: urn:newsml:reuters.com:*:nCCNnmtPWa
Further company coverage: AQS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange